mRNA |
JQ12 |
GDSC1000 |
pan-cancer |
AAC |
0.099 |
0.007 |
mRNA |
Sorafenib |
GDSC1000 |
pan-cancer |
AAC |
0.15 |
0.007 |
mRNA |
JQ-1:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.093 |
0.007 |
mRNA |
lenalidomide |
FIMM |
pan-cancer |
AAC |
0.44 |
0.008 |
mRNA |
decitabine:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.083 |
0.009 |
mRNA |
lovastatin |
CTRPv2 |
pan-cancer |
AAC |
-0.097 |
0.009 |
mRNA |
ML210 |
CTRPv2 |
pan-cancer |
AAC |
-0.085 |
0.01 |
mRNA |
LAQ824 |
GDSC1000 |
pan-cancer |
AAC |
0.091 |
0.01 |
mRNA |
NSC-207895 |
GDSC1000 |
pan-cancer |
AAC |
-0.088 |
0.01 |
mRNA |
niclosamide |
CTRPv2 |
pan-cancer |
AAC |
-0.092 |
0.01 |